Use of Sensors in the Treatment and Follow-up of Patients with Diabetes Mellitus

Overview

Journal Sensors (Basel)

Publisher MDPI

Specialty Biotechnology

Date 2011 Dec 14

PMID 22163609

Citations 4

Authors

Isabel Torres

Maria G Baena

Manuel Cayon

Jose Ortego-Rojo

Manuel Aguilar-Diosdado

Affiliations

Soon will be listed here.

Abstract

Glucose control is the cornerstone of Diabetes Mellitus (DM) treatment. Although self-regulation using capillary glycemia (SRCG) still remains the best procedure in clinical practice, continuous glucose monitoring systems (CGM) offer the possibility of continuous and dynamic assessment of interstitial glucose concentration. CGM systems have the potential to improve glycemic control while decreasing the incidence of hypoglycemia but the efficiency, compared with SRCG, is still debated. CGM systems have the greatest potential value in patients with hypoglycemic unawareness and in controlling daily fluctuations in blood glucose. The implementation of continuous monitoring in the standard clinical setting has not yet been established but a new generation of open and close loop subcutaneous insulin infusion devices are emerging making insulin treatment and glycemic control more reliable.

Citing Articles

Enabling the Internet of Mobile Crowdsourcing Health Things: A Mobile Fog Computing, Blockchain and IoT Based Continuous Glucose Monitoring System for Diabetes Mellitus Research and Care.

Fernandez-Carames T, Froiz-Miguez I, Blanco-Novoa O, Fraga-Lamas P Sensors (Basel). 2019; 19(15).

PMID: 31357725 PMC: 6696348. DOI: 10.3390/s19153319.

A Personalized Healthcare Monitoring System for Diabetic Patients by Utilizing BLE-Based Sensors and Real-Time Data Processing.

Alfian G, Syafrudin M, Ijaz M, Syaekhoni M, Fitriyani N, Rhee J Sensors (Basel). 2018; 18(7).

PMID: 29986473 PMC: 6068508. DOI: 10.3390/s18072183.

Italian contributions to the development of continuous glucose monitoring sensors for diabetes management.

Sparacino G, Zanon M, Facchinetti A, Zecchin C, Maran A, Cobelli C Sensors (Basel). 2012; 12(10):13753-80.

PMID: 23202020 PMC: 3545591. DOI: 10.3390/s121013753.

Encapsulation of FITC to monitor extracellular pH: a step towards the development of red blood cells as circulating blood analyte biosensors.

Ritter S, Milanick M, Meissner K Biomed Opt Express. 2011; 2(7):2012-21.

PMID: 21750776 PMC: 3130585. DOI: 10.1364/BOE.2.002012.

References

Robert J . Continuous monitoring of blood glucose. Horm Res. 2002; 57 Suppl 1:81-4. DOI: 10.1159/000053321. View

Amori R, Lau J, Pittas A . Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA. 2007; 298(2):194-206. DOI: 10.1001/jama.298.2.194. View

. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131):837-53. View

Heller S, Koenen C, Bode B . Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target.... Clin Ther. 2009; 31(10):2086-97. DOI: 10.1016/j.clinthera.2009.10.006. View

Hirsch I, Armstrong D, Bergenstal R, Buckingham B, Childs B, Clarke W . Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM). Diabetes Technol Ther. 2008; 10(4):232-44. DOI: 10.1089/dia.2008.0016. View

Reach G . Continuous glucose monitoring and diabetes health outcomes: a critical appraisal. Diabetes Technol Ther. 2008; 10(2):69-80. DOI: 10.1089/dia.2007.0261. View

Hanaire H, Lassmann-Vague V, Jeandidier N, Renard E, Tubiana-Rufi N, Vambergue A . Treatment of diabetes mellitus using an external insulin pump: the state of the art. Diabetes Metab. 2008; 34(4 Pt 2):401-23. DOI: 10.1016/S1262-3636(08)73972-7. View

Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven P . Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2008; 360(2):129-39. DOI: 10.1056/NEJMoa0808431. View

Hirsch I, Abelseth J, Bode B, Fischer J, Kaufman F, Mastrototaro J . Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther. 2008; 10(5):377-83. DOI: 10.1089/dia.2008.0068. View

10.

Pickup J, Sutton A . Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med. 2008; 25(7):765-74. DOI: 10.1111/j.1464-5491.2008.02486.x. View

11.

van Bon A, Kohinor M, Hoekstra J, von Basum G, DeVries J . Patients' perception and future acceptance of an artificial pancreas. J Diabetes Sci Technol. 2010; 4(3):596-602. PMC: 2901036. DOI: 10.1177/193229681000400313. View

12.

Oliver N, Toumazou C, Cass A, Johnston D . Glucose sensors: a review of current and emerging technology. Diabet Med. 2009; 26(3):197-210. DOI: 10.1111/j.1464-5491.2008.02642.x. View

13.

Dyck P, Kratz K, Karnes J, Litchy W, Klein R, Pach J . The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993; 43(4):817-24. DOI: 10.1212/wnl.43.4.817. View

14.

Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

15.

Klonoff D . Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care. 2005; 28(5):1231-9. DOI: 10.2337/diacare.28.5.1231. View

16.

Wild S, Roglic G, Green A, Sicree R, King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53. DOI: 10.2337/diacare.27.5.1047. View

17.

Currie C, Poole C, Papo N . An overview and commentary on retrospective, continuous glucose monitoring for the optimisation of care for people with diabetes. Curr Med Res Opin. 2009; 25(10):2389-400. DOI: 10.1185/03007990903094452. View

18.

Poscia A, Mascini M, Moscone D, Luzzana M, Caramenti G, Cremonesi P . A microdialysis technique for continuous subcutaneous glucose monitoring in diabetic patients (part 1). Biosens Bioelectron. 2003; 18(7):891-8. DOI: 10.1016/s0956-5663(02)00216-6. View

19.

Nathan D, Cleary P, Backlund J, Genuth S, Lachin J, Orchard T . Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005; 353(25):2643-53. PMC: 2637991. DOI: 10.1056/NEJMoa052187. View

20.

Torres I, Ortego J, Valencia I, Garcia-Palacios M, Aguilar-Diosdado M . Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues. Exp Clin Endocrinol Diabetes. 2009; 117(8):378-85. DOI: 10.1055/s-0029-1225337. View